Abeona Therapeutics
ABEO
ABEO
95 hedge funds and large institutions have $198M invested in Abeona Therapeutics in 2025 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 30 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
34% more funds holding
Funds holding: 71 → 95 (+24)
7.08% more ownership
Funds ownership: 61.14% → 68.22% (+7.1%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
95
Holding in Top 10
2
Calls
$14.7M
Puts
$2.43M
Top Buyers
| 1 | +$14.1M | |
| 2 | +$7.13M | |
| 3 | +$5.21M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.88M |
| 5 |
Morgan Stanley
New York
|
+$3.71M |
Top Sellers
| 1 | -$8.6M | |
| 2 | -$5.85M | |
| 3 | -$5.73M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.01M |
| 5 |
Millennium Management
New York
|
-$3.14M |
